• Home
  • About
  • Leadership
  • Capabilities
  • Clients
  • News
  • Connect
  • Join Us
  • Home
  • About
  • Leadership
  • Capabilities
  • Clients
  • News
  • Connect
  • Join Us
  • You Have a Great Story

    WE KNOW HOW TO TELL IT

  • ABOUT US

    Bioscribe is a top life science public relations agency dedicated to supporting organizations that are advancing biotechnology, genomics, bioinformatics, molecular diagnostics, and molecular and synthetic biology. Founded in the San Francisco Bay Area in 1997, our team members are located in California, New York, New Jersey, and Massachusetts. 

     

    For 20 years, we have been a leading boutique PR agency working with companies that powered the Human Genome Project and cutting-edge start-ups that are innovating to unlock its value. We've helped launch first, second and third-generation DNA sequencing systems, molecular biology lab tools and automation solutions, bioinformatics software, single cell analysis solutions, molecular diagnostics, DNA forensics systems, next-generation biotherapeutics, and vaccines.

     

    Our senior PR consultants and writers bring decades of experience and expertise in the biotech, diagnostics, pharma, and life science research markets. In addition to previous large PR agency experience, our team members have built in-house communications teams and covered the industry as journalists and editors of leading publications.

     

    Need help telling you story? Contact us at info [@] bioscribe.com

     

  • LEADERSHIP

    Nicole Litchfield, Bioscribe

    Nicole Litchfield

    President & CEO

    Nicole founded Bioscribe in 1997 in San Francisco to meet the communications needs of the emerging biotech industry. She has more than 20 years experience providing PR counsel to Fortune 500 companies, small start-ups, and non-profit associations in this industry.

    LinkedIn Profile

    Joan Kureczka

    Senior Vice President

    Joan is an industry veteran who started her career at Genentech in regulatory affairs and then became a biotech journalist before switching to the other side of the desk to provide strategic communications counsel to biotechnology companies, including efforts to support financing and corporate partnering initiatives.

    LinkedIn Profile

    Meredith Salisbury, Bioscribe

    Meredith Salisbury

    Vice President, Editorial Strategy

    Prior to joining Bioscribe, Meredith was CEO and Editor-in-Chief of GenomeWeb, the leading news and information service for scientists in the systems biology field.

    LinkedIn Profile

  • CAPABILITIES

    Media strategy & Media Relations

    Media Strategy & Relations

    Positioning and messaging
    Media audits, lists and monitoring
    Editorial calendars
    Journalist outreach
    Media training • Social media

    Editorial Strategy & Content Marketing

    Editorial Strategy & Content Marketing

    Editorial planning • Customer profiles Content development & editing
    Bylined articles • White papers
    Case studies • Marketing collateral
    Social media & website content

    Product Launches

    Product Launches & Publicity

    Messaging & positioning
     Publicity plans • Press releases
    News distribution • Media events
    Product placement
    Tradeshow support

    Blog content management

    Blog & Newsletter Content

    Editorial calendar planning • Content development • Managing approval process • Posting blogs

    Executive speaking & Thought Leadership

    Thought Leadership & Industry Recognition

    Presentation/Talk Development
    Op-Eds • Speaking opportunities
    • Awards programs

    Corproate communications

    Corporate Communications

    Branding • Finance milestones
    • Mergers & Expansions
     • Issues Management

  • OUR CLIENTS

    It's The Companies We Keep

    Our clients include innovative start-ups powering the DNA revolution, therapeutics companies, life science technologists, and financiers of healthcare innovation.

    Bioscribe Public Relations Logo

    Alzeca

    Novel imaging agents for the diagnosis of neurodegenerative diseases

    Houston, TX

     

    Alzeca is focused on developing novel targeted MRI imaging agents for the early diagnosis of Alzheimer’s disease and other neurodegenerative disorders. The company’s proprietary technology is based on nanoparticles that specifically bind to abnormal proteins that accumulate in the brain years before significant cognitive symptoms appear.

     

    Bioscribe Public Relations Logo

    Aravive Biologics

    Intercepting cancer's survival mechanisms

    Houston, TX
     

    Aravive is developing novel cancer therapeutics that spare healthy cells while targeting tumor adaptive responses and cancer evasion pathways. The company's primary therapeutics focus is the GAS6-AXL pathway, which can interrupt oncogenic signals and turn off the "survival switch" that allows cancer to grow, spread and acquire therapeutic resistance.

     

    Bionest Partners

    Actionable strategies for life sciences

    Paris, France

     

    Bionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.

     

    Bioscribe Public Relations Logo

    CytoDyn

    Developing the next class of antiviral agents for HIV

    Vancouver, WA

     

    CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. Their lead product candidate, Pro140, is the first self-administered antibody in late-stage clinical trials and works by blocking HIV from entering cells.

     

    Bioscribe Public Relations Logo

    IDbyDNA

    NGS-based meta-genomics tests for infectious diseases

    San Francisco, CA

     

    IDbyDNA's mission is to identify any microbe from any sample, anywhere in the world. A global leader in metagenomics, microbial genetics and data analytics, the company leverages advanced genome science and cutting-edge search technologies we are leading the transformation to bring precision medicine to infectious disease diagnosis.

     

    Labcyte

    The future of science is sound

    Sunnyvale, CA

     

    Labcyte is revolutionizing liquid handling. Its Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions.

     

    Luminex

    Breakthrough solutions to improve health and advance science

    Austin, TX

     

    Luminex aims to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers.

     

    Bioscribe Public Relations Logo

    MedCision

    MedCision is changing vital preclinical and clinical processes

    San Rafael, CA

     

    MedCision is the world leader in next-generation automated cell thawing for advanced therapies. The company develops and commercializes technologies that automate and standardize vital preclinical and clinical biologics handling for critical post-manufacturing processes.

    Bioscribe Public Relations Logo

    Nanōmix

    Analytical detection devices for the next generation of rapid
    point-of-care diagnostics

    Emeryville, CA

     

    Founded by physicists from the University of California-Berkeley and Lawrence Berkeley National Laboratory, Nanōmix is developing the next generation of mobile, point-of-care medical diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. .

     

    Bioscribe Public Relations Logo

    Notable Labs

    Mission-driven company aiming to transform the way cancer
    is treated

    San Francisco, CA

     

    Notable is developing a personalized treatment service for people with cancer that prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor. Focusing on individual patients and existing treatments, the company is discovering novel uses of drugs and defining mechanisms underlying development of cancer progression and drug resistance.

     

     

    Outcome Capital

    Investment bankers for middle market growth companies
    in life sciences

    Wellesley, Mass and Reston, VA

     

    Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services.

     

    PacBio logo

    Pacific Biosciences

    Third-generation DNA sequencing for complex
    genomics projects

    Menlo Park, CA

     

    Pacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the
    design, development and commercialization of innovative tools
    for biological research.

     

    Bioscribe Public Relations Logo

    Protagonist Therapeutics

    Clinical-stage biopharmaceutical company developing peptide-based targeted therapies for gastrointestinal diseases

    Newark, CA

     

    Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) to address significant unmet medical needs. Its primary focus is on developing
    first-in-class oral peptide drugs that specifically target biological pathways involved in gastrointestinal diseases.

     

    QIAGEN Bioinformatics

    The global leader in applications to quickly analyze and interpret genomic data

    Redwood City, CA

     

    Ingenuity Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems.

     

    Sage Logo

    Sage Science

    DNA size selection for next-gen sequencing

    Beverly, MA

     

    Sage Science develops products for sale to the Life Sciences research and Diagnostic laboratory markets. The company's mission is to provide new systems to streamline and improve sample preparation workflows.

     

    Bioscribe Public Relations Logo

    Sema4

    Health information company merging big data analytics with
    clinical diagnostics

    Stamford, CT

     

    Sema4 is a next-generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics.

     

     

    Bioscribe Public Relations Logo

    Tetra

    Restoring clarity of thought

    Grand Rapids, MI

     

    Tetra Discovery Partners is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, traumatic brain injury, major depression and schizophrenia. Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.

    Bioscribe Public Relations Logo

    TSG Therapeutics

    Developers of broad-spectrum anti-viral drugs that target
    the lipid envelope

    Singapore

     

    TSG Therapeutics is a preclinical-stage biopharmaceutical company on a mission to eliminate viral infectious disease. TSG has designed a novel class of broad-spectrum antiviral drugs that are adaptable, scalable, and therapeutically effective against a wide range of emerging and re-emerging viruses, such as Zika and Dengue.

    Bioscribe Public Relations Logo

    Two Pore Guys

    Developers of hand-held, battery-operated molecular
    detection systems

    Santa Cruz, CA

     

    Two Pore Guys (2PG) develops single-molecule sensing technologies that employ solid-state nanopores and biochemical reagents to create a versatile sample-in/results-out detection platform. 2PG’s first product is a handheld device that can use reagents from existing molecular or analyte diagnostic assays and provide accuracy and sensitivity rivaling sophisticated laboratory equipment.

     

    Bioscribe Public Relations Logo

    Past Clients

    Some of our past clients include:

     

    Allakos • Association for Molecular Pathology • Applied Biosystems
    BD Biosciences • Benchling • Biotique Systems • Cellular Research
    Chiron Corporation • Connetics Corporation • Cynvenio Biosystems • DNAnexus • DoubleTwist • Eos • Eurofins Genomics
    GE healthymagination • Gen9 • Genentech • GenoSpectra • IntegenX
    Invitrogen • Microsoft Health Solutions • Medtronic • Mohr Davidow Ventures • NanoString Technologies • Nektar • Omicia • Osel • PAG PaxVax • Personalis • RainDance Technologies • StationX • Varian Medical Systems • VitaPath Genetics • Zyomyx

     

  • OUR CLIENTS IN THE NEWS

    A sample of some of the stories we are helping to tell

    Companies To Watch: CytoDyn​

    April 6, 2018

    Opinion: We Must Make Data More Accessible for Bioinformatics Training​

    April 1, 2018

    Grand Rapids drug developer to test compound as treatment for genetic form of autism

    April 1, 2018

    New Oral Protagonists Due to Transform IBD's Plotline

    March 15, 2018

    Nanopore technology offers a way forward for point-of-care diagnostics​

    January 25, 2018

    Price controls would stifle innovation in the pharmaceutical industry​

    January 22, 2018

    Top 10 Stories Of 2017: Two Pore Guys, The IVD industry Today, And More

    January 2018

    IDbyDNA, Locus Biosciences Partner on CDx for CRISPR Antimicrobial

    January 3, 2018

    Pricing Front and Center

    January 1, 2018

    In The Lab Of The Future, Robots Run Experiments While Scientists Sleep​

    December 21, 2017

    The Most Innovative Companies of 2017

    December 17, 2017

    Researchers At Mount Sinai, Sema4 Develop Powerful New Method For Microbiome Analysis​

    December 12, 2017

    Start-Up Spotlight: Two Pore Guys, Gearing Up To Market Unique Handheld Nanopore Sensor After Inking Agreement With Monsanto​

    December 1, 2017

    Multiplexing Immunoassays: Technical Considerations for Optimal Performance​

    December 1, 2017

    Different Genes Active in Cancer Patients of Different Races​

    November 23, 2017

    Point-of-Care Testing Revs Up

    November 20, 2017

    Attracting venture capital in the life sciences industry: a data-driven approach​

    November 10, 2017

    10 Start-Ups to Watch

    November 6, 2017

    Hunting Structural Variants:
    Population by Population

    November 1, 2017

    IDbyDNA, ARUP Laboratories Introduce Technology to Diagnose Respiratory Infections​

    October 30, 2017

    Structural Variation Offers New Hope for Disease Associations and Gene Discovery

    October 23, 2017

    International Barcode of Life Project to Expand, Switch From Sanger to PacBio Sequencing​

    October 3, 2017

    Modernizing Medicine​

    September 11, 2017

    How Cognitive Bias Undermines Value Creation in Life Sciences M&A

    September 11, 2017

    Long-Read Sequencing Data Enables Structural Variant Discovery For Clinical And Disease Research

    September 11, 2017

    Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists

    September 6, 2017

    Alzeca Receives $11M for Early Alzheimer’s Detection Technology

    August 17, 2017

    Overcoming T-Cell Exclusion and Immune Evasion

    June 8, 2017

    Cancer drug developer to head Houston's Aravive Biologics​

    May 9, 2017

    Khosla-backed startup wins funding for the iPhone of molecular testing​

    April 25, 2017

    This Is Neat: Billionaire Vinod Khosla Is Betting On A Handheld Diagnostic Test

    April 25, 2017

    To Build a Better Healthcare System, Sharpen Our Basic Tools

    April 6, 2017

    This Scientist Wants to Sequence the Genomes of 8,000 Endangered Animals Before They’re Gone

    March 22, 2017

    Collaboration to Apply Functional Cancer Cell Screening for Individualized Cancer Treatment

    January 31, 2017

    Dual-action, Dual-indication Decoy Fights Tumors, Viruses

    January 13, 2017

     

    Startup Two Pore Guys Developing Nanopore Sensor, Aims to Enable Sequencing in the Future

     

    January 5, 2017

     

    Living therapeutics: Scientists Genetically Modify Bacteria to Deliver Drugs

     

    January, 2017

    Keeping the Gas Off AXL

    December 15, 2016

    Top 10 Innovations 2016

    December 1, 2016

    Ruga emerges from stealth mode with new name, location and $20M​

    November 21, 2016

    Next-Generation Sequencing Keeps Expanding

    November 22, 2016

    This Louisville company has a better way to make synthetic DNA​

    November 22, 2016

    The Genomic Genius of SMRT Sequencing​

    November 15, 2016

    The Cancer Bloodhounds

    November 8, 2016

    RIP for the Dreaded Colonoscopy Drink?

     

    October 17, 2016

    The Automated Lab

    October 17, 2016

    Individualized System Medicine: How We Can Save More Cancer Patients Now

    September 15, 2016

    Luminex Receives Regulatory Approval for IVD System​

    September 13, 2016

    Austin biotech firm joins fight against Zika

    August 8, 2016

    Cell Culture Advances Yield More Reliable Data for Cancer Research​

    July 26, 2016

    Germ Sleuths Go High Tech in Battle Against Drug Resistance

     

    June 19, 2016

    With Synthetic Biology, Drug Discovery is Going Virtual

    Summer, 2016

    Early Recurrence Detection: Analyzing DNA from Circulating Tumor Cells and Circulating Cell-Free DNA

    June 2016

    Searching for Superbugs: The Lab Looking for the Next Big Threat

    May 31, 2016

    Newly Revealed Epigenome Complexity Offers Clues for Regulatory Function

    May 6, 2016

    The Rebirth of Ex Vivo Cell Screening for Clinical Use

    April 2016

    Team of Rival Scientists Comes Together to Fight Zika

     

    March 30, 2016

    Xcell's New Incubator Promises Lifelike Conditions for Tests on Primary Cells 

    March 14, 2016

    New Triple Negative Breast Cancer Study Launched

    March 3, 2016

    Active VCs vs. Zombies: Dysfunctional Boards That Mess With M&A 

    February 22, 2016

    Long Reads and the Return of Reference Genomes

    February 18, 2016

    Soaring demand for genetic testing highlights need for streamlined data interpretation

    January 20, 2016

    Pharma R&D is Now Biomarker Driven

    January 2016

    Sounds of Molecular Biology

    January 2016

  • CONNECT WITH US

  • JOIN US

    We are a small group of senior, self-directed professionals passionate about helping clients communicate stories about life science innovations. We are currently recruiting PR counselors, media relations pros, scientific marketing content writers and MarCom experts who have experience working on biotech accounts. Please send a copy of your resume to us at info [@] bioscribe.com. If it looks like a great match, we'll be in touch.

Bioscribe, Inc. | San Francisco Bay Area, Boston and New York Metro | info [@] bioscribe.com | Copyright 2018